Decoy Therapeutics (DCOY) Other Non Operating Income (2019 - 2020)
Decoy Therapeutics (DCOY) posted quarterly Other Non Operating Income of -$3487.0 for Q4 2020, down 290.23% year-over-year from $1833.0 in Q1 2020, and down 101.95% quarter-over-quarter from $179027.0 in Q2 2020.
Decoy Therapeutics (DCOY) Other Non Operating Income (2019 - 2020) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Other Non Operating Income for 2 consecutive years, with -$3487.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Other Non Operating Income fell 290.23% year-over-year to -$3487.0; the TTM figure through Dec 2021 stood at -$3487.0 (down 101.97% YoY), while the FY2020 annual figure was $175540.0, up 9476.65% from the prior year.
- Other Non Operating Income slipped to -$3487.0 in Q4 2020 per DCOY's latest filing, from $179027.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $179027.0 in Q2 2020 and bottomed at -$3487.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -3,487.00 |
| Jun 30, 2020 | 179,027.00 |
| Dec 31, 2019 | 1,833.00 |